← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

EVP and Chief Commercial Officer Erik Harris sold $439K of Ultragenyx Pharmaceutical Inc.

Sold$438,959
$138.17Price
3,177Shares
−10%Stake

What RARE did after the filing

Prices for RARE after this filing aren't in yet.

Traded Mon, Mar 1. Filed Wed, Mar 3, 8:42 PM ET, after the close. Not investment advice.